Prognostic value of DNA ploidy and nuclear morphometry in prostate cancer treated with androgen deprivation

Author： Martnez-Jabaloyas J.M.   Ruiz-Cerda J.L.   Hernandez M.   Jimenez A.   Jimenez-Cruz F.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.59, Iss.5, 2002-05, pp. : 715-720

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic value of nuclear morphometry on needle biopsy from patients with prostate cancer: is volume-Weighted mean nuclear volume superior to other morphometric parameters?

By Zhang Y.H.   Kanamaru H.   Oyama N.   Miwa Y.   Suzuki Y.   Akino H.   Noriki S.   Okada K.  

Urology, Vol. 55, Iss. 3, 2000-03 ,pp. : 377-381

Elsevier

Access to resources Recommend Favorite

Newer approaches to androgen deprivation therapy in prostate cancer

By Pitts W.R.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 882-882

Elsevier

Access to resources Recommend Favorite

Prognostic Value of DNA Ploidy Patterns of Colorectal Adenocarcinoma: Univariate and Multivariate Analysis

By  

Digestive Surgery, Vol. 15, Iss. 6, 1998-11 ,pp. : 687-692

Karger

Access to resources Recommend Favorite

Androgen deprivation therapy for prostate cancer results in significant loss of bone density

By Wei J.T.   Gross M.   Jaffe C.A.   Gravlin K.   Lahaie M.   Faerber G.J.   Cooney K.A.  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 607-611

Elsevier

Access to resources Recommend Favorite

The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer

By Häggarth Lars   Auer Gert   Busch Christer   Norberg Mona   Häggman Michael   Egevad Lars  

Scandinavian Journal of Urology and Nephrology, Vol. 39, Iss. 5, 2005-11 ,pp. : 387-392

Informa Healthcare

Access to resources Recommend Favorite